Everything to do with the world of cosmetic product development, topical pharmaceutical development, and cosmetic regulations

Everything to do with the world of cosmetic product development, topical pharmaceutical development, and cosmetic regulations

  • Mitchum Recalls Products That Irritate Users’ Armpits
    What’s the cause of the problem with Mitchum’s deodorant that is causing irritation and even burns to its users, and what can be done about it?
  • Blackthorn Salt
    Blackthorn Salt is a new twist on a traditional method of making salt. It offers a salt made in a sustainable way. It might make an interesting alternative to Dead Sea salt as a scrub, bath salt or a headline ingredient for green brands.
  • Beautiful nails achieved by UV hardening
    TPO Ban – How Worried Should You Be?
    It’s getting some lurid coverage, but the EU’s ban on the use of TPO as a hardener in UV nail products isn’t as scary as it sounds at first hearing.
  • Period After Opening Symbol
    Do you know what this symbol means?  Have you even noticed it before?  You will find it on most, but not all, of the personal care products in your bathroom. What does it mean and should you take any notice of it?
  • Changes To General Product Liability Regulations in EU and UK
    Cosmetics are governed by the own regulations. Products that don’t fall under their own regulations such as eye Lash adhesive room sprays are governed by the GPSR rules.
  • Prostaglandin analogues for eyelash growth – do they work; are they dangerous?
    Eyelash serums promising longer, fuller lashes have become hugely popular—but how much science is really behind them? In this post, I take a closer look at prostaglandin analogues, the cleverly engineered molecules at the heart of these products, and explain why the evidence for their effectiveness is so underwhelming. I also look at the latest safety concerns raised by EU scientific advisors, and what that could mean for the future of these ingredients. This will be interesting If you’re curious about how (or if) these serums work, and what’s likely to happen next on the regulatory front.